Clinical Trial Update: A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A registry-style update on a Phase 1/2 trial evaluating the safety, efficacy, and pharmacokinetics of AZD6621 in adult males with metastatic prostate cancer, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• AZD6621 (AZD6621)

Snippet

Sponsor: AstraZeneca | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING